NASDAQ: VERO
Venus Concept Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their VERO stock forecasts and price targets.

Forecast return on equity

Is VERO forecast to generate an efficient return?

Company
-392.63%
Industry
16.36%
Market
348.21%
VERO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VERO forecast to generate an efficient return on assets?

Company
-14.09%
Industry
10.02%
VERO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VERO earnings per share forecast

What is VERO's earnings per share in the next 1 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$4.67

VERO revenue forecast

What is VERO's revenue in the next 1 years based on estimates from 4 analysts?

Avg 1 year Forecast
$67.1M+14%

VERO vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
VERO$1.55N/AN/A
AMIX$0.43N/AN/A
BBLG$1.72N/AN/A
AEMD$3.01$15.00+398.34%Hold
IVF$1.21N/AN/A

Venus Concept Stock Forecast FAQ

What is VERO's earnings growth forecast for 2026-2026?

(NASDAQ: VERO) Venus Concept's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Venus Concept's earnings in 2026 is -$54,614,000.

In 2026, VERO is forecast to generate -$8,685,079 in earnings, with the lowest earnings forecast at -$8,344,488 and the highest earnings forecast at -$8,940,523.

If you're new to stock investing, here's how to buy Venus Concept stock.

What is VERO's revenue growth forecast for 2026-2026?

(NASDAQ: VERO) Venus Concept's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Venus Concept's revenue in 2026 is $58,876,000.

In 2026, VERO is forecast to generate $124,776,899 in revenue, with the lowest revenue forecast at $119,883,688 and the highest revenue forecast at $128,446,808.

What is VERO's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: VERO) forecast ROA is -14.09%, which is lower than the forecast US Medical Devices industry average of 10.02%.

What is VERO's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: VERO) Venus Concept's current Earnings Per Share (EPS) is -$42.82. In 2026, VERO's EPS is forecast to hit -$4.67 (min: -$4.49, max: -$4.81).

What is VERO's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: VERO) forecast ROE is -392.63%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.